Podcasts about Biomedical engineering

Today, on the Hudson Mohawk Magazine, First, Mark Dunlea brings us coverage from a community Anti-Zionist shabatt held by Albany Jewish Voice for Peace. Then, Sina Basila Hickey talks with Elena McGrath the author of “The Limits of Revolution: Worker Citizens in a Bolivian Mining City” about the book and what motivated her to write it. Later on, Gaheul Yi talks with Jinah Ahn the owner and founder of Sunhees Farm and Kitchen a Korean farm and restaurant about her experience as a business owner. Finally, Erin Blanding talks with Dr. Shereka Banton about her experience as a scientist in the Biomedical Engineering space and the racial inequities and disparities in the medical field.

Send us Fan MailYesenia Avellaneda is an engineering leader whose career sits at the intersection of innovation, operations, and impact. Currently a Senior Project Engineer within Global Operations at Abbott, she has built a reputation for turning complex ideas into scalable, high-performing manufacturing systems. From leading New Product Introduction (NPI) efforts to executing international production transfers and launching entirely new facilities, Yesenia thrives where strategy meets execution. Her work has had measurable impact. She has led capital projects exceeding $5 million, driven production efficiency improvements, and implemented Lean manufacturing and Six Sigma methodologies to enhance quality and throughput. In one role, she helped boost line productivity by 200%, all while overseeing teams of 60+ personnel and ensuring compliance with rigorous FDA and regulatory standards . Her ability to align cross-functional teams—from product development to operations—has made her a key driver of successful product launches and operational excellence. Yesenia's academic foundation reflects her human-centered approach to engineering. She earned her bachelor's degree in Human Physiology from the University of Oregon and later completed a master's in Biomedical Engineering from the University of Portland. This unique combination allows her to bridge the gap between clinical needs and engineering solutions—an essential skill in the medical device industry. Beyond her technical and leadership accomplishments, Yesenia is deeply committed to giving back. As Regional Vice President for SHPE Region 6 and a longtime advocate for underrepresented communities in STEM, she actively works to create inclusive pathways for future engineers. She's also an experienced speaker, sharing insights on leadership, career growth, and navigating STEM as a first-generation professional. In this conversation, Yesenia brings a rare perspective—one that combines hands-on engineering, large-scale operational leadership, and a mission-driven approach to making a broader impact in both industry and community. LINKS: Yesenia Avellaneda LinkedIn: https://www.linkedin.com/in/yesenia-avellaneda/ https://shpe.org/ Aaron Moncur, host  Subscribe to the show to get notified so you don't miss new episodes every Friday.The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment like cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us at www.teampipeline.usWatch the show on YouTube: www.youtube.com/@TeamPipelineus 

Professor of ophthalmology Daniel Palanker is a physicist who has combined his skills in optics and electronics to create PRIMA – the Photovoltaic Retinal Implant. Inserted beneath the retina, it restores vision to patients blinded by retinal degeneration, allowing them to read and write – and with the next-generation software, to recognize faces. PRIMA's photovoltaic pixels act like tiny solar panels, converting light into electricity to stimulate the remaining retinal neurons. Better yet, the growing field of brain-computer interfaces may have implications beyond ophthalmology. “Unlike medicine, where the road ends with curing a disease or restoring lost function, the prospects for brain-machine interfaces may be infinite,” Palanker tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Daniel Palanker Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Daniel Palanker, a professor of ophthalmology and electrical engineering at Stanford University. (00:03:17) Path into Ophthalmology How Palanker's background in physics and optics led him to vision research. (00:04:33) How Vision Works A primer on the eye, retina, photoreceptors, and the neural code of sight. (00:08:50) Retinal Degeneration How diseases like macular degeneration and inherited retinal disorders damage vision. (00:13:18) The PRIMA Implant How a photovoltaic retinal implant converts light into electrical stimulation. (00:15:05) Augmented Reality Glasses How camera-equipped glasses amplify and project images to power the implant. (00:17:42) From Reading to Face Recognition Why grayscale vision is the next step toward recognizing faces. (00:20:18) Implanting the Device How the wireless chip is placed under the retina and powered by light. (00:21:45) Replaceable Vision Technology How future generations of implants could be swapped in for higher resolution. (00:22:28) Limits of Resolution Why geometry and proximity to neurons determine how small pixels can get. (00:24:00) Moving to 3D Electrodes How pillar-shaped electrodes help neurons move closer to the implant. (00:26:28) Clinical Path Forward The status of European trials, FDA discussions, and future patient access. (00:28:10) Safety and Real-World Use What trials reveal about surgical risks, durability, and patients using implants at home. (00:30:11) Future In a Minute Rapid-fire Q&A: neural coding, brain-machine interfaces, and restoring vision. Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What happens when a lifelong passion for science, innovation, and helping others comes together in one remarkable career? In this episode of The She Believed She Could™ Podcast, Allison Walsh sits down with Dr. Erica Stockwell, an advanced gynecologic surgeon with AdventHealth for Women, to discuss her groundbreaking work in women's healthcare, minimally invasive surgery, and medical innovation. Dr. Stockwell shares how her background in biomedical engineering, medicine, and business led her to become a pioneer in robotic surgery and surgical technology. From holding medical device patents to helping shape the future of AI-assisted healthcare, she offers a fascinating look at where women's health is headed and why innovation matters more than ever. But beyond her impressive accomplishments, Dr. Stockwell also reveals the deeply personal challenges that shaped her journey. During medical residency, she became a new mother while simultaneously caring for her infant daughter battling cancer. Her powerful story of perseverance, faith, and community support serves as a reminder that even the most successful women face valleys—and that resilience is built by continuing forward through them. Together, Allison and Dr. Stockwell explore leadership, confidence, endometriosis care, women's health advocacy, entrepreneurship, motherhood, and the courage it takes to keep believing in yourself when life gets hard. If you're looking for inspiration, practical wisdom, and a glimpse into the future of healthcare, this conversation is one you won't want to miss. What You'll Learn in This Episode: How innovation is reshaping women's healthcare The benefits of minimally invasive gynecologic surgery Emerging trends in robotic surgery and AI-assisted medicine Why endometriosis requires comprehensive, multidisciplinary care How to build resilience during life's hardest seasons The role of mentorship and support systems in success Why confidence is created through action Lessons on leadership, entrepreneurship, and impact How to navigate motherhood while pursuing ambitious goals The future of women's health technology This episode is sponsored by AdventHealth for Women. Learn more about their Women's Health Navigation Team and how they're making healthcare simpler for women and their families at AdventHealthForWomen.com. Positioned for Partnerships™ Mini Course - Turn your platform into a revenue-generating brand opportunity—without needing a massive following. Learn how to position your brand, create a high-converting media kit, and confidently pitch partnerships so brands instantly understand your value. 

Engineering a solution is one thing; making it work in a high-stakes clinical environment is another. This panel discussion features the minds who build the tech and the hands that use it. Leading bioengineers and frontline clinicians from NYU, NYU Abu Dhabi, the University of Michigan and the University of Maine deconstruct the challenges of medical device innovation. The topics include glaucoma and other chronic diseases such as metabolic, cardiovascular, and neurologic diseases. The discussion also touches on AI, robotics, and wearable technology to improve patient care. Panel Members Andreas Hielscher, Professor of of Biomedical Engineering, NYU Tandon School of Engineering Shy Shoham, Professor of Neuroscience and Ophthalmology, NYU School of Medicine and Tech4Health Giovanna Guidoboni, Professor of Electrical and Computer Engineering and Dean of Engineering and Computing, University of Maine Manjool Shah, Clinical Associate Professor of Ophthalmology and Visual Sciences and Associate Chair of Innovation, University of Michigan Sefy Paulose Joshi, Assistant Professor of Ophthalmology, NYU Langone Health Moderated by Yong-Ak (Rafael) Song, Professor of Mechanical Engineering and Bioengineering and 19 Washington Square North Faculty Fellow, NYUAD

In this episode of the MyHeart.net podcast, Dr. Alain Bouchard is joined by Dr. Norman Winn Seay to discuss chronic kidney disease, the connection between obesity and kidney health, and how early awareness, lifestyle changes, and newer medications can help protect kidney function.To learn more about kidney health and chronic kidney disease, explore our lastest article, Why Obesity Matters for Kidney Health.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

Hello voices from the bench community, John Wilson here and I wanted to share some news about the evolution of the Programill lineup. Most importantly, Ivoclar's new PrograMill 7. What stands out right away is the reduced air consumption this mill requires, but what you'll notice first is that impressive new touchscreen. For us, the biggest advantage has been increased spindle power. My laboratory's known for these larger cases with complex geometries, and I can tell you that extra power really makes a difference. Next time you see your Ivoclar representative, be sure to ask about the PrograMill 7 and tell them John Wilson sent you. Thank you. At exocad Insights in beautiful Mallorca, we finally caught up with Felix from Imagine USA—and the timing couldn't have been better. As an exocad dealer on the front lines of digital dentistry, Felix shared his excitement about the strong turnout, the familiar faces, and most importantly, the innovation coming from exocad. What stood out most? The new exocad Hub and its cloud-based capabilities, along with powerful AI-driven tools inside DentalDB designed for efficient batch processing. For Felix and the Imagine team, it's not just about seeing what's new—it's about putting it to the test. By running new features through their own production facility first, they ensure real-world performance before bringing solutions to their customers. Beyond the technology, Felix emphasized the value of being there in person—connecting face-to-face with partners, having meaningful conversations, and stepping back to see where the industry is headed. And of course, doing it all in Mallorca doesn't hurt either. This week at the Dental Laboratory Association of Texas Meeting 2026, the microphones stayed hot as three completely different conversations all circled around the same thing: how fast the dental lab industry is evolving. First up, the crew sat down with Tony Aliatim from Axis Dental Milling to talk about going from biomedical engineering and printing silicone heart models for surgeons… to becoming one of the go-to names in dental milling. From industrial machining roots in Michigan to AI-powered calibration systems and Straumann plug-and-play workflows, Tony breaks down how VersaMill machines are helping labs mill everything from zirconia to implant abutments faster, smarter, and safer. Along the way, the conversation dives into HyperDent, trade show madness, wet vs dry milling nightmares, and why dental technicians may not realize how close this industry really is to aerospace-level manufacturing. Then things shifted from mills to maintenance with Rebekah Serrago and Chris Wilson from Garland Dental Services. What started decades ago as a garage-based repair business fixing handpieces has grown into one of the industry's best-kept secrets for equipment sales, service, and support. Rebekah shares the story of growing up folding flyers for her father's repair company before eventually becoming CEO and expanding Garland into a massive online sales and service operation supporting everything from ovens to mills. Chris joins in to talk preventative maintenance, service certifications, keeping ancient ovens alive, and why labs desperately need dealers that actually understand the equipment they sell. It's equal parts family-business story, repair shop wisdom, and hilarious behind-the-scenes dental lab banter. Finally, the future officially arrived when the podcast crew sat down with Antoine Coppens from Relu and orthodontic lab owner Christian Saurman of New England Orthodontic Laboratory. What started as four engineering students experimenting with AI in Belgium somehow turned into fully automated dental workflows capable of designing surgical guides, night guards, models, and restorations in minutes. The conversation explores how AI is reshaping lab workflows, reducing manual design time, integrating directly into LMS systems, and even learning individual lab preferences. Christian explains how his custom-built orthodontic lab management system helped eliminate workflow chaos and automate huge portions of production, while Antoine gives a fascinating look into where dental AI is headed next. Between AI-generated appliances, automated scan checks, and self-learning workflows, this episode feels less like science fiction and more like a preview of what labs will look like over the next five years.Special Guests: Antoine Coppens, Chris Wilson, Christian Saurman, Rebekah Serrago, and Tony Aliatim.

Recorded live in USC's Wallis Annenberg Hall in April 2026, this special episode focuses on the key issues surrounding data centers, the focus of Season 3. What exactly are data centers? Who benefits from their development? What are the drawbacks? Experts will answer those questions – and yours – alongside host Chip Zukoski, USC's Robert E. Vivian Professor in Energy Resources and Professor of Chemical Engineering and Materials Science and Biomedical Engineering.  Featured panelists include:Shaolei Ren, Associate Professor of Electrical and Computer Engineering at the University of California, RiversideKelly Twomley Sanders, Professor, Sonny Astani Department of Civil and Environmental EngineeringSean Wilcock, Vice President of Business Development & Services at Imperial Valley Economic Development CorporationYou can follow us on Instagram at⁠ ⁠⁠⁠@usc_electricfutures⁠⁠⁠⁠.Additional resources from USC's Annenberg Center for Climate Journalism and Communication:The Data Center Next Door, Key Considerations for Communities Navigating Data Center DevelopmentHow to Create a Climate Podcast-----Electric Futures is an original podcast from the University of Southern California, hosted by me, Charles Zukoski, the Vivian Professor of Chemical Engineering and Materials Science and the former USC Provost. This series was executive produced by Allison Agsten, the director of USC's Annenberg Center for Climate Journalism and Communication.USC Annenberg professor Mallory Carra is our supervising producer. Natalie Lopez and Spencer Cline are our associate producers. Imperial Valley College student Tahjah Fortune is our production assistant. Our live episode was edited and sound designed by Spencer Cline.Technical supervision was provided by Sebastian Grubaugh, Tom Norris, Ray Barkley, Victor Figueroa and S-R Meredith. Video interviews were directed by Makayla Idelburg. Rhysea Argawal, Nadia Lozano Murphy, Anahita Mehra, Avidha Raha, and Lina Rehbein provided live event support.With special thanks to Leslie Berestein Rojas, Edward Lifson, Jim Yoder, and Pawan Ahuja.All music and sound effects are used with express permission under unlimited blanket license authority from Epidemic Sound. 

We learn about a new injectable microgel to help reduce bleeding in infants who require surgical care. In a mice model, it reduced bleeding by at least 50%. Ashley Brown, Professor of Biomedical Engineering at North Carolina State University and UNC Chapel Hill tells presenter Claudia Hammond more about this new material her team has designed.Joined by Professor of Global Health and Epidemiology at Boston University in the US, Dr Matthew Fox, Claudia hears about a mystery illness that is being investigated by health officials in Burundi, which has caused five deaths and sickened thirty-five people. So far lab analysis of the illness - which causes fever, vomiting, and diarrhoea - has been negative for Ebola and Marburg viruses, Rift Valley fever, and others.We hear about influential analysis from Cochrane which has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients. Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives. However, their report has also provoked a vicious backlash from equally esteemed scientists who label it as fundamentally flawed.We're joined by health journalist Katie Silver in Mexico, who brings us the news that the President, Claudia Sheinbaum, has announced the details of a plan to introduce universal healthcare – no mean feat in country of 130 million people.And we hear about an experiment that was done by academics to see if they could trick AI chatbots into believing in an entirely fake disease. Presenter: Claudia Hammond Producer: Jonathan Blackwell

Our latest episode of QuidelOrtho Science Bytes addresses a public health paradox: while early-stage syphilis cases in the U.S. are declining, congenital syphilis continues to rise despite being entirely preventable. Host Josh Casey is joined by Andrea Ott‑Vasconi, Director of Scientific Affairs and Regulatory at QuidelOrtho, to unpack CDC data and explain why missed or delayed screening during pregnancy is driving congenital infections. Together, they explore how syphilis testing works, when infections are being missed and why repeat screening is essential, especially later in pregnancy.   About Our Speaker:  Andrea Ott-Vasconi, Director of Scientific Affairs and Regulatory at QuidelOrtho Andrea holds a Bachelor of Science in Biomedical Engineering from Johns Hopkins University and an MBA from New York University. Most recently, she earned a Master of Public Health from Imperial College London. With over 20 years of experience in the medical device industry, Andrea has worked in many different roles, including product development and clinical marketing. In her current role at QuidelOrtho, she manages a team responsible for the development of educational content, scientific publications and evidence generation. Andrea is passionate about increasing awareness of the clinical value of laboratory tests and their impact on improving patient outcomes.

Dr. Ana Luisa Trejos is an Associate Professor of Electrical and Computer Engineering as well as Biomedical Engineering at Western University in Canada. She is also an Associate Scientist at the Lawson Health Research Institute. Ana Luisa's research combines mechanical, electrical, computer, and software engineering to develop smart machines that can perceive what is happening in the environment and react intelligently. In particular, she is designing wearable mechatronic technologies that can help people recover from mobility problems due to a musculoskeletal injury or a movement disorder like Parkinson's disease. When she's not at work, Ana Luisa enjoys hanging out with her family, reading, putting together jigsaw puzzles, hiking, swimming, and running. She has also been having fun renovating her house, and she has recently been working on completely remodeling one of their bathrooms. Ana Luisa was awarded her B.Sc. degree in mechanical engineering from the University of Costa Rica and her M.A.Sc. in mechanical engineering from the University of British Columbia. She worked as an Applications Engineer for Progressive Moulded Products in Ontario from 2000-2003. She then joined the team at Canadian Surgical Technologies & Advanced Robotics at Western University as a research engineer. Ana Luisa later attended graduate school at Western University where she was awarded her Ph.D. degree in electrical and computer engineering in 2012. Ana Luisa has been awarded the IEEE London Section Outstanding Women in Engineering Award and the For Inspiration and Recognition of Science and Technology (FIRST) Canada District Volunteer Appreciation Award. In our interview, Ana Luisa shares more about her life and research.

In this deeply raw and eye-opening episode, Susan sits down with Nicole Bell to uncover the devastating reality of chronic Lyme disease, misdiagnosis, and the critical gaps in modern testing.Nicole shares the powerful and heartbreaking story of her husband's journey, from subtle personality changes and memory loss to a misdiagnosis of early-onset Alzheimer's… and ultimately, the truth that was missed for far too long. His experience sheds light on a much bigger issue: how thousands of people are falling through the cracks of a system that isn't equipped to detect complex, stealth infections.This conversation goes far beyond Lyme disease. It's about advocacy. It's about asking better questions. And it's about understanding that symptoms are not random, they are signals.Susan and Nicole break down why traditional testing often fails, how infections can mimic neurological and psychiatric conditions, and why getting the right diagnosis could change everything.If you've ever felt like something is “off” in your body but no one can explain why, this episode is for you.In This Episode:How Lyme and co-infections can mimic conditions like Alzheimer's, anxiety, and psychiatric disordersLearn more about our guest Nicole BellNicole is an experienced executive in the medical device and diagnostics industries in roles ranging from science and engineering to business development and marketing. At Advanced Liquid Logic, a company that sold to Illumina for $96M, she ran product management and interfaced with top companies across medical diagnostics. At TransEnterix Surgical, she served as the Vice President of Research and Development, driving the development of the surgical robot from breadboard design to FDA submission in 3 years and propelling the company's market cap to over $500M.She holds a Bachelor's and Master's degree from MIT in Materials Science and Engineering, as well as a Master's of Science degree in Biomedical Engineering from Duke University. Her best-selling and award-winning memoir, What Lurks in the Woods, vividly details her family's experience with undiagnosed tickborne infection. This firsthand knowledge of the devastating impact of misdiagnosed chronic illness fuels her passion to drive a new diagnostic standard of care for the industry. She also served as the primary author of “The State of Lyme Disease Research in the United States,” and regularly collaborates with the Center for Lyme Action to change the political landscape for Lyme Disease and related coinfections.RESOURCES:Connect with Nicole Bell:Website: https://www.galaxydx.com/Instagram: https://www.instagram.com/galaxydiagnostics/Facebook: https://www.facebook.com/galaxydxYouTube: https://www.youtube.com/@GalaxyDiagnosticsVideosLinkedIn: https://www.linkedin.com/company/galaxy-diagnostics-inc-/posts/?feedView=allhttps://healthyawakening.co/2026/04/13/episode119/Connect with Susan: https://healthyawakening.co/Visit the website: healthyawakening.co/podcastFind listening links here: https://healthyawakening.co/linksP.S. Want reminders about episodes? Sign up for our newsletter, you can find the link on our podcast page! https://healthyawakening.co/podcast

Kelly Byrne's path to credit markets started in engineering, where systems, risk management, and infrastructure were foundational. Today, as Founder and CEO of Mountain Point Credit, Kelly is applying those principles to build a systematic, data-driven investment platform built around a disciplined risk ranking process, rigorous diversification, and repeatable, transparent decision-making.In this episode, Kelly shares his journey from engineering to portfolio management, the lessons he carried through nearly two decades at Voya Investment Management, and why he believes the loan market remains largely analog. We discuss what it really takes to evolve credit investing: from building the right systems and frameworks to paving the road toward a more efficient, technology-enabled market where a systematic approach can unlock new opportunities for investors.About Kelly:Kelly Byrne is the Founder and Chief Executive Officer of Mountain Point Credit, responsible for leading the firm's vision to bring a systematic investment approach to the loan market. MPC was founded by Kelly Byrne in partnership with Eagle Point Credit. Prior to founding Mountain Point, Mr. Byrne spent 18 years at Voya Investment Management, most recently as Senior Portfolio Manager and Head of Capital Markets, where he helped grow assets from $2 billion to $30 billion. He held leadership roles across credit products and built the systems and processes that underpin operational and performance risk management. He now focuses on leveraging market data and technology to streamline and improve portfolio management. Mr. Byrne holds a BSE in Biomedical Engineering and an MBA from Arizona State University and is a Chartered Financial Analyst charter holder.

Learn about the journey from academic researcher to entrepreneur and what it takes to launch a successful spin out company. Academics are specialists in their disciplines and research areas but very few have any expertise in running a business. So, while their discoveries may hold commercial potential, it is rarely a simple or easy process translating this knowledge into a saleable product or service. To demystify the process of research commercialisation, on this episode we hear from a US-based biomedical researcher who has launched and grown five spin-out companies over the last 25 years. Ashutosh Chilkoti is the Alan L. Kaganov Professor of Biomedical Engineering in the Pratt School of Engineering at Duke University and the brains behind companies including PhaseBio Pharmaceuticals, Sentilus and Insolere Bio. He runs the Chilkoti research group and has driven a number of initiatives at Duke designed to support entrepreneurship among students and staff. As well as describing his own varied start-up experiences, he breaks down the process of developing a research finding into a business and offers insight on what investors look for and how institutions can best support their academics efforts in commercialisation. For anyone interested in commercialisation and enterprise, this conversation offers practical takeaways and useful insights to guide your decision-making. And for more advice on this process, check out our latest spotlight: A step-by-step guide to commercialising your research.

Guests:Dr Eoin O'Cearbhaill, Associate Professor in Biomedical Engineering at University College DublinDr Shane Bergin, Physicist at UCDDr Lara Dungan, Immunologist and Medic

In this episode of the MyHeart.net podcast, Dr. Alain Bouchard is joined by Dr. Chris DeGroat, a cardiologist at Cardiology Specialists of Birmingham, to discuss all things peripheral artery disease.To learn more about new methods for combating peripheral artery disease, explore our article, The Next Frontier in Peripheral Artery Disease Treatment.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

Join Dr. Ben Holmes, CEO and Co-Founder of Nanochon, for a strategic look at the high-stakes world of medical device innovation. With a Ph.D. in biomedical engineering and a background in aerospace engineering, Ben has spent nearly a decade navigating the "long runway" of medtech. In this episode, we discuss how Nanochon is moving toward its first-in-human clinical trials with the Chondrograft™—a 3D-printed synthetic implant—and how founders can create tangible enterprise value years before their first dollar of commercial revenue.

On March 26, 2026, we held our annual UTSA Neuroscience Symposium entitled "From Place Cells to Cognition", featuring 5 speakers presenting original research on the cognitive functions of hippocampal place cells. They discussed the firing patterns of place cells during exploration of cognitive maps, anticipating future movements, recall of previously visited locations, and imagining the movement of objects in the environment. After the symposium, I met with the speakers to review some of the themes that emerged throughout the day.Speakers:Francesco Savelli, Assistant Professor, Department of Neuroscience, Developmental and Regenerative Biology, UTSAAnnabelle Singer, Associate Professor, Department of Biomedical Engineering, Georgia Institute of Technology and Emory UniversityAlbert Lee, Associate Professor, Department of Neurology and Howard Hughes Medical Institute, Harvard UniversityJill Leutgeb, Professor, Department of Neurobiology, University of California San DiegoKamran Diba, Associate Professor, Department of Anesthesiology, University of MichiganHost:Charles Wilson, Department of Neuroscience, Developmental and Regenerative Biology, UTSAThanks to James Tepper for original music

Season three of Electric Futures, the USC energy transition podcast, takes listeners back to California's Imperial Valley, a region explored throughout season one in connection with the county's potential for lithium extraction. A lot has changed since then. Plans for lithium extraction are stalled due to lawsuits and a new set of developers has come to town: hyperscalers. Host Charles Zukoski, the Robert E. Vivian Professor in Energy Resources and Professor of Chemical Engineering and Materials Science and Biomedical Engineering, has been tracking the news since last summer, when word began to circulate that one of the largest data centers in the country might tap into the region's rich geothermal resources.Demand for data centers—the physical embodiment of AI —is growing so rapidly that their global electricity consumption will more than double by 2030. But pushback from communities is also growing. Concerned residents worry about rising electricity bills, environmental degradation, and AI itself. Does the benefit of data center development in places like Imperial Valley outweigh the costs?

Send us Fan MailPharma has spent decades building a graveyard of failed drugs — but hidden inside that data may be treatments that actually worked… for someone.Vin Singh is Founder and CEO of BullFrog AI ( https://bullfrogai.com/ ), a company working at the intersection of machine learning, causal modeling, and drug development.BullFrog is focused on a fundamental problem in biopharma — not just how to analyze increasingly large datasets, but how to extract meaningful cause-and-effect relationships from them. Their platform integrates data preparation, analysis, and network-based modeling to help research teams better understand biological mechanisms, identify patient subgroups, and improve clinical trial design.Vin brings a deep mix of technical, operational, and entrepreneurial experience to this challenge. Prior to founding BullFrog, he held leadership roles across the life sciences ecosystem, including serving as Global Director of the Cell Therapy Business at Thermo Fisher Scientific, where he oversaw services supporting clinical and commercial-stage therapies. He also founded and led Next Healthcare, a company focused on adult stem cell and skin cell banking, and was an early co-founder at MaxCyte, helping build foundational technologies in cell engineering.In addition to his operating roles, Vin has been active in the innovation ecosystem as a Mentor in Residence at Johns Hopkins Technology Ventures.Vin holds an MBA in Finance from Johns Hopkins University, a Master's in Biomedical Engineering from Rensselaer Polytechnic Institute, and a Bachelor's in Electrical Engineering from Rutgers University — a background that spans engineering, biology, and business.#CausalAI #DrugDevelopment #Biotech #ClinicalTrials #PrecisionMedicine #AIinHealthcare #PharmaInnovation #FailedDrugs #OncologyResearch #PancreaticCancer #FutureOfMedicine #MachineLearning #Biopharma #TranslationalMedicine #DigitalHealth #MedicalInnovation #DataScience #ClinicalResearch #AIinBiotech #HealthcareInnovationSupport the show

Don Watenpaugh, PhD, D, ABSM, is a scientist, sleep consultant, and data artist. He earned his PhD in Physiology at UC Davis and is board-certified in sleep medicine by the American Board of Sleep Medicine (ABSM). He directed a large urban sleep clinic for 13 years and currently serves as an adjunct faculty member in the Department of Physiology and Anatomy at the University of North Texas Health Science Center and in the Department of Biomedical Engineering at the University of Texas at Arlington.In this episode, Bethany Lewis welcomes back her uncle, Dr. Don Watenpaugh, for a third deep dive into the science of concussion recovery. The conversation focuses heavily on the physiological underpinnings of common post-concussion symptoms. Dr. Watenpaugh explains the role of the vestibular system (specifically the "rocks in your head" called otoliths) in causing dizziness and vertigo, and how this relates to Dysautonomia (autonomic nervous system imbalance). He also explores cutting-edge therapies for sleep disruption, including neurofeedback and transcranial stimulation. The episode concludes with a critical discussion on the under-recognized risks of concussion in the elderly population and a valuable "internet hack" for finding reliable, peer-reviewed research.Key Topics & Resources Mentioned1. Vestibular System & BPPVConcept: The otoliths (calcium carbonate crystals) in the inner ear help the body sense gravity and movement. A concussion can dislodge these "rocks," leading to Benign Paroxysmal Positional Vertigo (BPPV) , dizziness, and disorientation.Impact: Increases fall risk (leading to re-injury), causes sensitivity to movement (e.g., elevators, bending down), and can disrupt sleep by altering spatial awareness.Treatment: Specialized vestibular physical therapists use specific maneuvers (like the Epley maneuver) to reposition the crystals and "re-educate" the system.2. Dysautonomia (Autonomic Nervous System Imbalance)Concept: The concussion can cause an "adrenergic storm," leading to a dominance of the sympathetic nervous system (fight or flight). This makes it difficult for the body to switch to the parasympathetic state (rest and digest), which is necessary for healing.Symptoms: Random heart rate spikes while resting, profuse sweating, feeling faint upon standing (POTS-like symptoms), and digestive or hormonal issues.Treatment: Sub-threshold exercise (exercising up to the point of symptom onset and then stopping) and High-Intensity Interval Training (HIIT) can help retrain the nervous system's resilience. Listen to The Concussion Coach Podcast episode 37 for more information on how to implement effective HIIT training: 37. Post Concussion Syndrome, Dysautonomia, & Intervals: An Interview with Dr. Mark Allen, PhD3. Sleep & Advanced TherapiesConcept of Brain Fog: Delta waves (slow waves associated with deep sleep) appearing during wakefulness, which is counterproductive to cognitive function.Therapies Discussed:Neurofeedback: Training the brain to reduce inappropriate delta waves during the day to improve wakefulness and potentially improve sleep drive at night.Transcranial Direct Current Stimulation (tDCS): A non-invasive therapy that uses small electrical currents applied to the scalp during sleep to encourage Delta (slow wave) sleep.Transcranial Magnetic Stimulation (TMS): Using magnetic fields to stimulate nerve cells in the brain to treat post-concussion depression and headaches, which indirectly improves sleep.Near-Infrared Light (Red Light Therapy): A therapy mentioned for overall brain recovery (also listen to a previous episode on the Neuronic device: Episode 120: https://youtu.be/Juoz5SApHUg).

Join Daniel Delubac, CEO of IORGANBIO, for a deep dive into the breakthrough technologies reshaping modern medicine. From non-invasive prenatal testing to the first AI-agentic platforms for synthetic chemistry, Daniel has been at the center of the world's most significant biotech innovations. In this episode, we explore how IORGANBIO is merging first-principles engineering with AI to manufacture human bioequivalent cells and organoids at scale—replacing outdated animal models and paving the way for accessible, $n$-of-one regenerative medicine.

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Bradley Hubbard, MD, discuss the following articles from the March 2026 issue: "Apixaban (Eliquis) for Venous Thromboembolic Prophylaxis following Abdominoplasty: Establishing a Safety and Efficacy Profile" by Bricker, Ferenz, Moradian, et al. Read the article for FREE: https://bit.ly/EliquisAbdVTE Special guest Dr. Bradley Hubbard is a nationally renowned aesthetic surgeon and currently practices in Dallas, Texas, where he is the Fellowship Director of the esteemed Dallas Plastic Surgery Institute. He completed his undergraduate degree at Rensselaer Polytechnic Institute in Biomedical Engineering, followed by medical school at Upstate Medical University, and then attended the University of Missouri for plastic surgery residency at UT Southwestern Medical Center in Dallas. He completed an additional year of training, specializing in aesthetic surgery. Dr. Hubbard has published many scientific research articles, review articles, and book chapters on a variety of aesthetic and reconstructive plastic surgery topics.  READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMarch26Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Welcome back, everyone, to another episode of Aigoracast. Our guest today is Dr. Riccardo Accolla. Dr. Riccardo Accolla is a neuroscientist and food innovation leader dedicated to creating more resilient food systems through technology and human-centric insights. As the Director of Innovation at Thimus, he applies his expertise in multisensory perception, reward, and emotion to develop product strategies that resonate with consumers on a cognitive level. With over 20 years of experience, Riccardo's career spans leadership roles at global flavor houses and food-tech startups. He previously led the design of sustainability-tracking software at ripe.io and founded A-T4H Consulting to support "better-for-planet" food solutions. Riccardo holds a PhD in Neuroscience from the Swiss Polytechnic Federal Institute (EPFL) and a Master's in Biomedical Engineering from the Polytechnic School of Milan.   Social Links & Resources LinkedIn: https://www.linkedin.com/in/riccardoaccolla/ Company: https://www.thimus.com/ Expertise Areas: * Multisensory Food Perception Neuro-Innovation Sustainable Food Systems Consumer Emotions and Reward Mechanisms  

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Bradley Hubbard, MD, discuss the following articles from the March 2026 issue: "A Closer Look at Prepectoral Implant-Based Breast Reconstruction: A Matched-Pair Comparison of Direct-to Implant versus Two-Stage Outcomes" by Amro, Ryan, Ewing, et al. Read the article for FREE: https://bit.ly/DTIvs2Stage Special guest Dr. Bradley Hubbard is a nationally renowned aesthetic surgeon and currently practices in Dallas, Texas, where he is the Fellowship Director of the esteemed Dallas Plastic Surgery Institute. He completed his undergraduate degree at Rensselaer Polytechnic Institute in Biomedical Engineering, followed by medical school at Upstate Medical University, and then attended the University of Missouri for plastic surgery residency at UT Southwestern Medical Center in Dallas. He completed an additional year of training, specializing in aesthetic surgery. Dr. Hubbard has published many scientific research articles, review articles, and book chapters on a variety of aesthetic and reconstructive plastic surgery topics.  READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMarch26Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Bradley Hubbard, MD, discuss the following articles from the March 2026 issue: "Simplifying Breast Reduction: An Effective Approach to Defining the Ideal Breast Meridian" by Kim, Kim, Ock, and Lee. Read the article for FREE: https://bit.ly/BreastMeridian Special guest Dr. Bradley Hubbard is a nationally renowned aesthetic surgeon and currently practices in Dallas, Texas, where he is the Fellowship Director of the esteemed Dallas Plastic Surgery Institute. He completed his undergraduate degree at Rensselaer Polytechnic Institute in Biomedical Engineering, followed by medical school at Upstate Medical University, and then attended the University of Missouri for plastic surgery residency at UT Southwestern Medical Center in Dallas. He completed an additional year of training, specializing in aesthetic surgery. Dr. Hubbard has published many scientific research articles, review articles, and book chapters on a variety of aesthetic and reconstructive plastic surgery topics.  READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMarch26Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Powering the Future with India's Ancient WisdomProf Ganti Suryanarayana Murthy is the National Coordinator of the Indian Knowledge Systems (IKS) Division, Ministry of Education, Government of India, at AICTE, New Delhi. He also serves as Professor in the Department of Biosciences and Biomedical Engineering at IIT Indore.He was among the distinguished guest speakers at the 2nd Global Vedic Conference held at Prasanthi Nilayam in January 2026, where he offered valuable insights from the integrated perspective of Indian Knowledge Systems, contemporary science, and education.Subsequently, during his interaction at the Sri Sathya Sai Media Centre, he eloquently expounded on the relevance, revival, and renaissance of ancient India's sacred knowledge traditions, highlighting their enduring significance in the modern world.

Is fatty liver disease reversible through diet?Amy Goss, PhD, Associate Professor of Nutrition Sciences at UAB and Registered Dietitian, returns to the MyHeart.net podcast to discuss metabolic-associated steatotic liver disease (MASLD), also known as fatty liver disease, and her research on how a carbohydrate-restricted diet may help reduce liver fat in those already diagnosed with the condition. Learn practical tips on making dietary changes that are both effective and sustainable.To read more about how exercise, diet, and other lifestyle changes may help with MASLD by exploring our article, Lifestyle Intervention as the Foundation of Care in Obesity-Related Fatty Liver Disease (MASLD).About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

In this episode I'm talking to Dr. Nicolas Rouleau, Ph.D. about his Essay An Immortal Stream of Consciousness: The scientific evidence for the survival of consciousness after permanent bodily death.This Essay was a Bigelow Institute for Consciousness Studies Essay Competition WinnerIs experience possible after death? "An immortal stream of consciousness: The scientific evidence for the survival of consciousness after permanent bodily death" was the title of Nicolas Rouleau's award-winning 2021 submission for the Bigelow Institute for Consciousness Studies' international essay competition. Adapted here as a short book, the essay describes a transmissive theory of consciousness inspired by William James and supported by experimental evidence in the field of bioelectromagnetism including the works of the author (Rouleau) and his former doctoral mentor, Michael A. Persinger. It is one of few scientific theories that reconciles physicalism with survival of consciousness after bodily death.BioDr. Nicolas Rouleau is a neuroscientist, bioengineer, and Assistant Professor of Health Sciences at Wilfrid Laurier University. He is also an Adjunct Professor of Biomedical Engineering at Tufts University and Affiliate Scientist at the Allen Discovery Center at Tufts. Dr. Rouleau was the last PhD student of Michael Persinger of Laurentian University, whose work on the electromagnetic bases of consciousness inspired Rouleau to pursue his dissertation on the material-like properties of brain tissues, including their capacity to filter electromagnetic fields. In 2017, he joined the Allen Discovery Center at Tufts University as a Postdoctoral Researcher and was a founding member of David Kaplan's Initiative for Neural Science, Disease, & Engineering at Tufts, focusing on minimal cognitive responses in bioengineered brain models.As a post-doc, Dr. Rouleau published several 3D tissue models of Alzheimer's Disease and traumatic brain injury. During the research freeze of the COVID pandemic, he wrote an award-winning essay on the topic of transmissive consciousness for the Bigelow Institute of Consciousness Studies, which garnered international attention. In 2023, Dr. Rouleau became a faculty member at Laurier and is now a PI of the Self-Organizing Units Lab (SOUL), which is supported by Tri-Council awards to investigate the mechanisms of embodied cognition and synthetic biological intelligences in customizable, bioengineered neural tissues. He also co-directs (with his colleague, Dr. Murugan) the Center for Tissue Plasticity and Biophysics (TPAB) at Laurier. He is most interested in the fundamental and scale-invariant properties of cognitive systems as well as the pursuit of unifying principles that reconcile organic neural function with analogous phenomena in cells, machines, and non-neural organisms.  https://www.bigelowinstitute.org/wp-content/uploads/2022/10/rouleau-immortal-consciousness.pdf https://www.pastliveshypnosis.co.uk/https://www.patreon.com/ourparanormalafterlifeMy book 'Verified Near Death Experiences' https://www.amazon.com/dp/B0DXKRGDFP Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of the MyHeart.net podcast, Dr. Alain Bouchard discusses the interplay between Heart Failure with Preserved Ejection Fraction, or HFpEF, and obesity with Dr. Michelle Kittleson, Director of Heart Failure Research at the Smidt Heart Institute at Cedars-Sinai.Learn more about the diagnosis, challenges, and management of this condition by exploring our article, Managing Obesity in Heart Failure with Preserved Ejection Fraction (HFpEF).About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

Last year, the National Institutes of Health drastically cut funding for medical research. This disrupted the work of academics and researchers across the country. Clinical trials and scientific projects were cancelled, and funding for ongoing research was revoked. This meant big cuts in funding to research institutions here in Connecticut. UConn lost $41 million from research grant terminations and unexpected non-renewals. Today, we hear how these cuts are impacting research institutions in our state and the future of science. GUESTS: Rob Stein: Correspondent and Senior Editor, on NPR’s Science Desk Evan Morris: Professor of Radiology and Biomedical Imaging and of Biomedical Engineering at Yale School of Medicine Diane Owens: mother of a pediatric patient with neurofibromatosis Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

Book Worm's Story Snacks | The Bionic Behemoth How do you fix a robot leg from the inside out? Join the Book Worm in this high-tech story snack and shrink down to a microscopic size to explore the inner workings of a "Hero Leg"—a cutting-edge prosthetic built for a brave elephant calf named Mali. What starts as a curious sanctuary visit quickly turns into a mechanical emergency when sticky monsoon mud and a snapped "Data Vine" threaten to leave Mali's new step in the dust. Join the brilliant Dr. Chai, navigate the clinking "Gear Forest," bridge sparking electrical gaps with Insulated Clips, and help Mali perform a ground-shaking Calibration Dance to restore her balance. Together, you'll discover the magic of Biomedical Engineering, the power of Sensors, and how technology can be a tool for kindness—all through teamwork, logic, and a little imagination.

Hardware security is not a new problem, but it is rapidly expanding in both consumer and medical domains due to hyperconnectivity. Medical devices and counterfeit medicines represent a fundamental security challenge. In particular, although counterfeit medicines are not a new issue,the problem continues to worsen as counterfeiting practices become increasingly sophisticated. The counterfeiting of biomedical products poses a serious threat to patient safety, public health, and economic stability in both developed and developing countries, and many current countermeasures remain vulnerable because they provide limited security. In this talk, we will share our work on biomedical hardware security with a focus on pharmaceutical products. We present cyber-physical biomedical security technologies that encode dosage information and authentication into edible biomaterials, enabling serialization, track-and-trace, and authentication at the dosage level. This approach empowers patients to play an active role in combating counterfeit medicines. About the speaker: Young Kim is a professor in the Weldon School of Biomedical Engineering and holds the titles of University Faculty Scholar and Showalter Faculty Scholar at Purdue University. His research centers on co-creating hardware(devices) and software (models) for large-scale societal and healthcare applications. His lab develops hybrid machine learning by combining data analytics with models grounded in optical spectroscopy and light-matter interactions to move beyond big-data, compute-intensive AI and leverage engineers' domain expertise. His work spans optical imaging and spectroscopy, mesoscopic physics, meta materials, cancer research, hardware security, and global health,unified by machine learning and data analytics. His research has been funded by a diverse range of agencies, including NIH, CDC, VA, AFOSR, USAID and Gates Foundation. His primary applications are in global health and rural community health, which address large-scale societal and healthcare challenges in mutually reinforcing ways.

(02:20) Pills that communicate from the stomach could improve medication adherence(07:13) Innovative Solutions for Tracking Medication(10:46) The Technology Behind the Smart Pill(13:42) Conclusion and Future Implications This episode was brought to you by Mouser, our go-to source for electronics parts for any hobby or prototype. Click HERE to learn more about making healthcare smarter with electronics. Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

All in a Day's Work features many scientists and many entrepreneurs, but rarely does it have scientists who are also entrepreneurs. That's where Dr. Nisha Maheshwari, co-founder and CEO of CaroRhythm, comes in. In this episode, producer Ahmed Ashour speaks with the recent NYU alum about their interest in the sciences as a child, their experience launching a medical device as a student, and their advice for scientists and engineers looking to enter the world of entrepreneurship. Nisha recently received their PhD in Biomedical Engineering from the NYU Tandon School of Engineering. They are interested in product design of non-invasive or minimally invasive medical devices for diagnostics and treatment of various diseases. Nisha is currently working on a low-cost system for the detection and quantification of peripheral arterial disease (PAD). This includes the expansion of the existing functionality and improvement of the clinical utility, accuracy and user-friendliness. They have channeled their passion for social good, activism, and engineering to be at the forefront of change in the healthcare industry as the CEO of CaroRhythm, a medical device company with a focus on bridging critical gaps in stroke care.For a full transcript of this episode, please email career.communications@nyu.edu.

Mia Horowitz, PhD, Tel Aviv University; Aitor Aguirre, PhD, Michigan State University, Michigan, USA; and Ying Sun, PhD, University of Cincinnati, discuss the use of organoid models in lysosomal disorder research and drug development.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session3-organoids-and-lab-grown-models-in-lysosomal-disorders/Learning ObjectivesDescribe the use of heart organoid models to better understand the pathophysiology of lysosomal disorders and its clinical relevanceDescribe the use and application of brain organoid models in neuropathic Gaucher disease research and treatmentFacultyMia Horowitz, PhD, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University.Aitor Aguirre, PhD, Associate Professor of Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Chief, Division of Developmental and Stem Cell Biology (IQ), Director, MSU Stem Cell Core, Michigan State University.Ying Sun, PhD, Professor, Cincinnati Children's Hospital Medical Center, University of Cincinnati.DisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Mia Horowitz, PhDDr. Horowitz has no relevant financial relationships to disclose.Aitor Aguirre, PhDDr. Aguirre has no relevant financial relationships to disclose.Ying Sun, PhDDr. Sun receives research support from Enkefalos Biosciences and Yuhan Corporation.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

Some aging-related changes can be hidden. Danny Wang, professor of neurology, radiology, and biomedical engineering and Director of Imaging Technology Innovation at the Stevens Neuroimaging and Informatics Institute at the University of Southern California, examines these. Dr. Danny JJ Wang is a Professor of Neurology, Radiology and Biomedical Engineering, and Director of Imaging Technology Innovation […]

Could immortality ever be possible for humans? It sounds like something from a sci-fi movie, but floating in oceans around the world is a tiny, transparent jellyfish that could hold the answer...Turritopsis dohrnii, known as 'the immortal jellyfish', isn't immortal in the true sense of word - it can die - but it has a nifty way of avoiding that fate. In times of stress, this miniscule jelly can biologically reverse its aging process, reverting from 'medusa' (adult jellyfish) to a juvenile form and starting its life-cycle again; potentially ad infinitum.Abilities like these could hold the key to - if not exactly 'immortality', then at least regenerative or long-life treatments for humans in future. But of course there's a catch: these extremely delicate jellyfish can still easily die from predation, disease, or environmental threats and are extremely difficult to keep healthy in a lab environment. Hannah and Dara hear about new technology that could change the way we study immortal jellyfish, and discover various other super-abilities in the animal kingdom that could help in our quest for healthier, longer lives.Contributors: - Miranda Lowe, Principal Curator of Crustacea and Cnidaria at London's Natural History Museum - Alex Cagan, Assistant Professor in the Department of Genetics, Department of Pathology and Department of Vet Medicine at the University of Cambridge - Maria Pia Miglietta, Associate Professor of Marine Biology at Texas A&M University in Galveston - Nicole Xu, Assistant Professor of Mechanical Engineering, Robotics and Biomedical Engineering at the University of Colorado, BoulderProducer: Lucy Taylor Executive Producer: Sasha Feachem A BBC Studios Production

From reluctant engineer to global changemaker, Nimmi Ramanujam bridges art, science, and empathy to revolutionize women's health. Her groundbreaking innovations — from the Pocket Colposcope to the Trisol therapy — are transforming cancer care, advancing inclusion, and inspiring a new era of purpose-driven engineering.00:35- About Prof RamanujamNirmala (Nimmi) Ramanujam is the Robert W. Carr Professor of Biomedical Engineering, Professor of Cancer Pharmacology and Cancer Biology, and Global Health at Duke University.She founded the Center for Global Women's Health Technologies(GWHT) in 2013 to reshape women's health through technology innovation.

In this episode of MyHeart.net, cardiologist Dr. Alan Bouchard sits down with Dr. Timothy Garvey, Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham, to discuss the evolving definition of obesity as a disease. Drawing from The Lancet's 2025 clinical framework, Dr. Garvey explains when excess adiposity begins to impair organ function, how this redefinition changes patient care, and why understanding obesity as a chronic disease is essential for preventing cardiometabolic complications.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

Visual Expertise and Diagnostic Accuracy with Claudia Mello-Thoms, PhDIn this episode of The Girl Doc Survival Guide, Christine interviews Claudia Mello-Thoms, PhD, an Associate Professor of Radiology and Biomedical Engineering at the University of Iowa. Claudia discusses her research on visual search, medical image perception, and why errors occur in reading radiological images. Key topics include the use of eye tracking to detect unconscious viewing patterns, the different diagnostic approaches of experts and novices in pathology, and the concept of visual templates aiding rapid diagnosis. Claudia shares insights into how experts efficiently use low magnification to guide further detailed inspection, and the cognitive load differences between experienced and inexperienced diagnosticians.00:00 Introduction to Claudia Mello-Thoms00:47 Eye Tracking in Radiology02:12 Pathologists and Microscopic Slides06:56 Visual Search Strategies in Medical Imaging09:42 Expert vs. Novice: Cognitive Processes11:35 Templates and Rapid Recognition20:48 Conclusion and Next Episode Teaser

Dr. Kathryn (Katie) Whitehead is an Assistant Professor in Chemical Engineering at Carnegie Mellon University where she also holds a courtesy appointment in Biomedical Engineering. Katie received her bachelor's degree in chemical engineering from the University of Delaware and her PhD in chemical engineering from the University of California, Santa Barbara. Afterwards, she conducted postdoctoral research in the Koch Institute for Integrative Cancer Research at MIT. Katie has received numerous awards and honors, including the DARPA Young Faculty Award, the DARPA Director's Fellowship, the Controlled Release Society Capsugel/Pfizer Oral Drug Delivery Award, the Diabetes Technology Society Peterson Research Award, a UC Graduate Research and Education in Adaptive Biotechnology Fellowship, an NIH Ruth Kirschstein National Research Service Award Fellowship, the Kun Li Award for Excellence in Education, the Popular Science Brilliant 10 Award, and very recently the 2018 National Institutes of Health (NIH) Director's New Innovator Award. She has also been named an MIT Technology Review Innovator Under 35 and the 2016 Young Innovator Award from Cellular and Molecular Bioengineering (CMBE). In our interview, Katie speaks more about her experiences in life and science.

Clinician-scientist Jill Helms is an expert on healing. Until about age 30, people heal easily, she says, but later on, not so well. Regenerative medicine suggests avenues for improvement, she promises. Her research focuses on understanding the physical and molecular processes of healing to design better therapies. One approach awakens “sleeper” stem cells to aid healing, a new drug in trial regenerates bone, and another avenue targets infections that appear near medical devices using gum-like tissues that create sealing barriers. In many ways, nature remains our best model for healing, Helms tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Jill HelmsConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Jill Helms, a professor of surgery at Stanford University.(00:03:42) Why Study Wound HealingJill shares what led her to explore how the body repairs itself after injury.(00:04:23) How Healing WorksExplanation of physical signals, stem cells, and the stages of tissue repair.(00:07:23) Healing Declines with AgeHow healing quality and speed drop significantly after age thirty.(00:10:48) Physical vs. Biological SignalsThe biological and physical signals that work together to guide healing.(00:13:21) Regenerative MedicineTherapies designed to restore healing capacity and accelerate repair.(00:16:55) Infection and ImplantsChallenges of preventing infections around skin penetrating medical devices.(00:21:54) Nature's BlueprintUsing biological models to inspire self-renewing wound interfaces.(00:26:19)  Biomimicry and Evolutionary InsightWhat scientists are learning from animals to inform human tissue repair.(00:30:51) Future In a MinuteRapid-fire Q&A: scientific curiosity, young researchers, and supportive environments.(00:33:04) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

(5:00) – A Patch for the HeartThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about advances of 3D printing in the medical space.  Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

[Part 2] Getting Cats Vegan is Possible and Imperative  Listen to the second half of this article about why it's not only possible to feed domestic cats a vegan diet, but it's imperative. Written by Karthik Sekar, Ph.D. at AfterMeatBook.com #vegan #plantbased #plantbasedbriefing #microbialfermentation #plantbasedmeat #aftermeat #vegancats #veganpetfood #humanhealth  ================== Original Post: https://forum.effectivealtruism.org/posts/AFPXXepkgitbvTtpH/getting-cats-vegan-is-possible-and-imperative  ================== Related Episodes: 193: Cultured Meat for Pet Food: Game Changer! https://sites.libsyn.com/342677/193-cultured-meat-for-pet-food-game-changer-by-paul-benton-at-unchainedtvcom  200: [Part 1] Vegan Cats 101: Nutrients, Not Ingredients is What Really Matters https://sites.libsyn.com/342677/200-vegan-cats-101-nutrients-not-ingredients-is-what-really-matters  201: [Part 2] Vegan Cats 101: Nutrients, Not Ingredients, Is What Really Matters https://sites.libsyn.com/342677/201-part-2-vegan-cats-101-nutrients-not-ingredients-is-what-really-matters-by-vecadoca-0  211: Cultured Meat: The Future of Pet Food https://sites.libsyn.com/342677/211-cultured-meat-the-future-of-pet-food-by-shannon-falconer-at-becauseanimalscom  233: ‘Should Cats & Dogs Eat Cows & Chickens?' & ‘Farmed vs Cultured Meat: The Shocking Environmental Costs' https://sites.libsyn.com/342677/233-should-cats-dogs-eat-cows-chickens-farmed-vs-cultured-meat-the-shocking-environmental-costs-by-becauseanimalscom  318: Bravo Packing: The Dirty Business of Pet Food Slaughterhouses https://sites.libsyn.com/342677/318-bravo-packing-the-dirty-business-of-pet-food-slaughterhouses-by-erin-wing-at-animaloutlookorg  325: The Secret Horrors and Products of Rendering Dead Animals. https://sites.libsyn.com/342677/325-the-secret-horrors-and-products-of-rendering-dead-animals-from-animals-in-print-posted-at-all-creaturesorg  337: Avoid Toxins from Bioaccumulation with Vegan Cat & Dog Food https://sites.libsyn.com/342677/337-avoid-toxins-from-bioaccumulation-with-vegan-cat-dog-food-by-vecadoca  349: 5 Ways to Explain Why My Cat/Dog is Now Vegan https://sites.libsyn.com/342677/349-5-ways-to-explain-why-my-catdog-is-now-vegan-by-vecadoca  649: Feeding Our Pets To Death. What's Really in Pet Food? https://sites.libsyn.com/342677/649-feeding-our-pets-to-death-whats-really-in-pet-food-by-emily-moran-barwick-at-bitesizeveganorg  ================= Karthik Sekar, Ph.D is the author of After Meat: The Case for an Amazing Meat-Free World. He is a trained scientist and engineer. He finished his B.S. in Biomedical Engineering from the University of North Carolina, his PhD in Chemical Engineering from Northwestern University, and a postdoctoral position in Systems Biology at ETH Zurich. He currently works on the front lines of the alternative food industry in the San Francisco Bay Area. Please visit www.aftermeatbook.com to learn more. 100% of the proceeds of AFTER MEAT will be donated to charity. ==================== FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/     

[Part 1] Getting Cats Vegan is Possible and Imperative.  The amount of meat that cats eat is significant. Transitioning domestic cats to eating vegan would do much good for the environment and animal welfare. Written by Karthik Sekar, Ph.D. at AfterMeatBook.com #vegan #plantbased #plantbasedbriefing #microbialfermentation #plantbasedmeat #aftermeat #vegancats #veganpetfood #humanhealth  ================== Original Post: https://forum.effectivealtruism.org/posts/AFPXXepkgitbvTtpH/getting-cats-vegan-is-possible-and-imperative  ================== Karthik Sekar, Ph.D is the author of After Meat: The Case for an Amazing Meat-Free World. He is a trained scientist and engineer. He finished his B.S. in Biomedical Engineering from the University of North Carolina, his PhD in Chemical Engineering from Northwestern University, and a postdoctoral position in Systems Biology at ETH Zurich. He currently works on the front lines of the alternative food industry in the San Francisco Bay Area. Please visit www.aftermeatbook.com to learn more. 100% of the proceeds of AFTER MEAT will be donated to charity. ==================== FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

Matt Dowling is the Chief Scientific Officer and Director at Medcura Team. Matt completed his graduate work at the Fischell Department of Bioengineering at the University of Maryland (UMD), after completing his undergrad in Chemical Engineering from the University of Notre Dame. At UMD, he was awarded the Fischell Fellowship in Biomedical Engineering for his innovative ideas in drug delivery systems. Matt then co-created gel-e, a novel biomaterial platform, raising several initial grants to develop the technology and to launch Medcura as a corporate entity. Matt was the recipient of the Dean's Doctoral Research Award from the UMD Clark School of Engineering for his work on chitosan-based self-assembled soft materials for use in wound treatment. He has been the Principal Investigator on $10 million in non-dilutive grant awards to Medcura; these have been used to achieve 5 FDA clearances, 2 Breakthrough Device Designations, 28 issued patents, and 10+ peer-reviewed publications in high-impact journals. Matt's work has been featured on several US and international media outlets including the BBC TV program, Brave New World with Stephen Hawking. He's also the lead vocalist in the band, Swoll.Swollhttps://www.swollmusic.com/Light the NightLLS is on a mission to cure blood cancers and improve quality of life for the nearly 1.7 million people in the U.S. living with or in remission from blood cancer.Help Team Zavadowski reach our fundraising goal! Thank you for your generous donations:https://pages.lls.org/ltn/fdk/Montcomd25/rsmith--Get in touch: robinsmithshow@gmail.comCall the hotline: +1 (301) 458-0883Follow Robin on Insight Timer: https://insighttimer.com/robinsmithBecome a supporter on Patreon: https://www.patreon.com/therobinsmithshowGot a question? We'd love to hear from you!

On October 9, 1975, CBC listeners across the country heard David Suzuki introduce the very first episode of Quirks & Quarks. 50 years and thousands of interviews later, Quirks is still going strong, bringing wonders from the world of science to listeners, old and new.On October 7, 2025 we celebrated with an anniversary show in front of a live audience at the Perimeter Institute for Theoretical Physics in Waterloo, Ontario. We had guests from a range of scientific disciplines looking at what we've learned in the last 50 years, and hazarding some risky predictions about what the next half century could hold. Our panelists were:Evan Fraser, Director of Arrell Food Institute and Professor of Geography at the University of Guelph, co-chair of the Canadian Food Policy Advisory Council, a fellow of the Pierre Elliot Trudeau foundation, and a fellow of the Royal Canadian Geographical Society.Katie Mack, Hawking Chair in Cosmology and Science Communication at the Perimeter Institute for Theoretical Physics.Luke Stark, Assistant Professor in the Faculty of Information & Media Studies at Western University in London, Ontario, and a Canadian Institute for Advanced Research Azrieli Global Scholar with the Future Flourishing Program.Laura Tozer, Assistant Professor of Environmental Studies at the University of Toronto and director of the Climate Policy & Action Lab at the Department of Physical and Environmental Sciences at the University of Toronto Scarborough.Ana Luisa Trejos, a professor in the Department Electrical and Computer Engineering and the School of Biomedical Engineering and Canada Research chair in wearable mechatronics at Western University in London, Ontario.Yvonne Bombard, professor at the University of Toronto and scientist and Canada Research Chair at St. Michael's Hospital, Unity Health Toronto, where she directs the Genomics Health Services Research Program.

Yue Zhao's career began with aspirations rooted in a desire to help people, initially thinking she would become a doctor. However, her path led her into the tech industry, where she spent over 15 years as a product executive in Silicon Valley.  Discovering the power of executive and leadership coaching became a pivotal point in her career. Inspired by her experiences and driven by her commitment to support underrepresented groups, Yue transitioned from a tech executive to a full-time executive coach. She now focuses on advancing the careers of women and minorities by leveraging her unique insights and personal journey. Through her Substack newsletter, "The Uncommon Executive," and her coaching work, Yue shares valuable lessons on leadership, overcoming challenges, and creating more inclusive workplaces. Yue has coached hundreds of aspiring executives since 2016, is an instructor at Reforge and Maven and is the author of the Uncommon Executive: Breakthrough to the C-Suite as a Minority. She's also been a VC back founder, venture partner at Life X Ventures and a consultant at McKinsey and Company. Yue has an MBA from Harvard Business School and a BS in Biomedical Engineering from the University of California at Berkeley    What You Will Hear in This Episode:    02:16 Youi's Journey: From Aspirations to Reality 03:52 Discovering Executive Coaching 06:22 Challenges and Triumphs in Silicon Valley 09:20 Leveraging Unique Perspectives 13:37 Coaching Women and Minorities 17:27 Addressing Gender Bias and DEI Efforts 22:03 Building a Web of Influence 23:04 Challenges in Career Advancement 25:03 The Importance of Advocacy and Relationships 33:24 Creating Inclusive Work Environments   Quotes “Being able to empathize with multiple different perspectives is crucial.” “Finding those moments where you can say, okay, who I am, and where I naturally come from, gives me a step up.” “If I do the work and I do it really well, that'll get me ahead.” “When you've been in environments where you see what great looks like, you're like, ‘This should just be everywhere.”   Mentioned: The Uncommon Executive subastack LinkedIn   eConnect with Bonnie Online Course for Ambitious Women: https://www.female-career-accelerator-online.com/ Substack Newsletter: Own Your Ambition Gendered Ageism Survey Results Forbes article 5 Tips to own the superpower of your age IAMMusicGroup   Purchase my book Not Done Yet on Amazon:    If you enjoyed this episode of Badass Women Podcast, then make sure to subscribe to the podcast and drop us a five-star review  

Alan interviews Tushar Sharma. Tushar Sharma grew up in a small village in India - but he had big plans. He graduated from IIT in Madras with a biotechnology degree. He completed his masters and PhD at UT Austin in Biomedical Engineering. In 2019, he invented a non-invasive surgical procedure for prostate patients that has minimal side effects. Website: www.VivifiMedical.com